Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. Her PhD research focused on occupational exposures and head and neck cancer. 

She then joined the UMQVC at the University hospital of Besancon where she provides methodological support for clinicians in designing, analyzing and promoting results from clinical research. She is particularly involved into research on breast cancer or gynecologic cancers. She is statistical editor among the Cochrane Lung Cancer Group. She also provides lessons in biostatistics to medical school students and in research methodology to public health master’s degree students. Since 2017, she is the head of the module "Monitoring of HRQoL in clincial practice".

Main areas of expertise

  • Epidemiology
  • Clinical trials and clinical research
  • Biostatistics
  • Oncology
  • Meta-analyses and Cochrane methodology
  • Occupational epidemiology


Main ongoing external collaboration

- Cochrane Lung Cancer Group


Latest publications

sample

The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...

Posted by : , Mme. Joëlle FRITZSCH, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Journal name : La revue de l'infirmière

sample

AbstractBackground: Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis have changed the first-line...

Posted by : Dr. Sophie PAGET-BAILLY
Journal name : Cochrane Database Syst Rev

sample

ABSTRACTBACKGROUND: Two main therapies, pazopanib and sunitinib, are used in the first-line setting for metastatic renal...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, , Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH,
Journal name : Health and Quality of Life Outcomes

sample

AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : European Journal of Cancer

sample

AbstractIntroduction: Survivors of viral ARDS are at risk of long-term physical, functional and neuropsychological...

Posted by : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Dr. Sophie PAGET-BAILLY
Journal name : Annals of Intensive Care

sample

AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...

Posted by : Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : Expert Review of Anticancer Therapy

sample

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...

Posted by : Dr. Sophie PAGET-BAILLY, , , Mme. Joëlle FRITZSCH, Mr. Antoine FALCOZ,
Journal name : Quality of Life Research

sample

AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : Breast Cancer Research

sample

AbstractBackground: Ageing is associated with an increased prevalence of comorbidities and sarcopenia as well as a...

Posted by : Dr. Sophie PAGET-BAILLY
Journal name : BMJ Open

sample

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...

Posted by : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Journal name : PlosOne

Latest News

Latest tools

The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY

Discover Pr Bonnetain's keynote during the canceropôle IDF' seminar on rare tumours.Listen to the keynote here.Discover...

Posted by : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN

Posted by : Mme. Joëlle FRITZSCH, , Dr. Sophie PAGET-BAILLY

Posted by : Dr. Sophie PAGET-BAILLY

On Friday 17 November, the Quality of Life in Cancer conference, organized by the UMQVC with the support of the Pôle de...

Posted by : Dr. Sophie PAGET-BAILLY, , Mme. Joëlle FRITZSCH

2015-2024 © Copyright - UMQVC.org

Website by Pearlweb